Prestige Consumer Healthcare Inc.’s fiscal 2021, ended on 31 March, benefited from the company’s strategic focus during the pandemic on health conditions that consumers may be more inclined than ever to treat at home without a doctor’s visit.
“Share performance for a broad portfolio had an outstanding fiscal ’21, especially considering rapidly shifting consumer habits due to COVID,” said president and CEO Ron Lombardi in a 6 May call discussing the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?